The Melanie Avalon Biohacking Podcast Episode #342 - Sarah Morgan Sarah Morgan is currently the CEO and co-founder of InstaMed Pharmaceuticals focused on innovative delivery technologies for peptides, hormones and functional pharma actives
Tumor suppressive functions of p53
667 Current treatments for DN primarily focus on symptom management, lacking effectiveness in reversing or halting disease progression
PRF treatment works by taking blood from your body, placing the blood sample inside a centrifuge, spinning the sample at a lower speed, and gathering the PRF from the vial
Currently, FOXO4-DRI is being investigated for its role in studies involving cellular senescence, transcription factor regulation, DNA damage response signaling, and aging-related cellular models